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In recent years, various approaches have been implemented in an attempt to develop 
devices to effectively control the release of drugs. These controlled delivery systems can be 
localized in specific regions of the body, such as vaginal, intrauterine, subcutaneous, or 
corneal sites. Although some degree of systemic absorption is inevitable, with its associated 
side effects, local delivery appears to be a more efficient alternative, with limited adverse 
effects and increased patient compliance, particularly during long-term treatment. The 
quantification of the Active Pharmaceutical Ingredient (API) content in such device is very 
time-consuming. According to the Process Analytical Technology (PAT) concept, the aim of 
this study is to compare a near infrared (NIR) and a Raman methods able to quantify the 
API of implant during the manufacturing  process.  
MATERIALS AND METHODS 
The model formulation consists in pharmaceutical implants manufactured by co-extrusion 
technique with an equipment from Scamex (Crosne, France). The co-extruder uses two 
small single screws. The first (12mm) is responsible for the mixing between the API and 
Ethyl-Vinyl-Acetate (EVA) from Celanese (Dallas, USA)  forming the implant core, while the 
second (8mm) adds a membrane around the core. The implant diameter is adjusted in real 
time during the manufacturing process by means of a laser measurement. Figure 1 shows 
the extruder during these experiments. 
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Near Infrared and Raman Spectrometer settings         
Figure 1: Co-extruder equipment. 
Figure 5: Loading factors of the NIR PLS model. 
Figure 3: NIR spectra of API, EVA and Final Product. 
Figure 2: Interfacing of the extruder by NIR and Raman fiber optic probe. 
Figure 8: Raman predictions versus reference method results for 
calibration and validation sets. 
The extruder die was non invasively interfaced with a multipurpose analyzer Fourier 
transform near infrared spectrometer (MPA, Bruker Optics, Ettlingen, Germany) equipped 
with a semiconductor room temperature sulfide lead (RT-PbS) detector and with a dispersive 
spectrometer RamanStation 400F (Perkin Elmer, MA, USA) equipped with a two-
dimensional CCD detector (1024 × 256 pixel sensor) (Fig.2). The NIR spectra were collected 
with a NIR reflectance probe for solids. The spectra were collected with the Opus Software 
6.5 (Bruker Optics). Each spectrum was the average of 10 scans and the resolution was 8 
cm-1 over the range from 12500 to 3600 cm-1. The Raman spectra were collected with a 
Raman reflectance probe for solids and liquids. The spectra were collected with the 
Spectrum Software 6.3.2.0151 (Perkin Elmer). The laser excitation wavelength used was 
785 nm. The spectral coverage was 250–3400 cm−1 and the spectral resolution was equal to 
4cm−1. A cosmic ray filter was applied. The time necessary for a NIR or a Raman 
measurement was 5 seconds. 
Calibration Samples      
5 implants production batches were included in the calibration of the NIR and Raman 
methods with respectively 35, 40, 50, 60, 65 % (w/w) of API. 6 implants for each 
concentration were used for calibration. 
External Validation Samples  
3 implants production batches were included in the calibration of the NIR and Raman 
methods with 50 % (w/w) of API. 6 implants per production were used for external 
validation. 
Multivariate Data Analysis   
Standard Normal Variate (SNV) and mean center using cross-validation random subsets was performed on the 
calibration set to build the prediction NIR model with PLS Toolbox 5.0 for Matlab version 7.6 (Eigenvector Research 
Inc, Wenatchee, USA). First derivative and mean center using cross-validation random subsets was performed on 
the calibration set to build the prediction Raman model. The random subsets cross-validation was performed with 5 
data splits, on 30 samples and with 11 iterations. The model ability to predict the API content was further tested with 
the external validation set.  
RESULTS 
As can be seen on Figures 3 and 4, a spectral range linked to the API and EVA was manually selected for the 
calibration of the NIR model and all spectral range were selected for the Raman model calibration. To check its 
adequacy, the loading factors (Figures 5 and 6) were compared with the raw materials spectra displayed in Figures 
3 and 4. It was found that the loading factors highlighted spectral bands belonging to the API and the EVA. Indeed, 
it is the ratio between both ingredients that mainly defines the 5 different API content formulations. Consequently, 
the selected spectral range was found to be adequate regarding the purpose of the NIR  and Raman models: to 
quantify accurately the API content of the implant. 
Cross-validation based on random subsets was carried out to select the optimal number of PLS factors. For the 
random subsets cross-validation,  3 PLS factors were selected for the NIR model and 2 PLS factors were selected 
for the Raman model as the Root Mean Squared Error of Calibration (RMSEC) was the lowest from this number of 
factors. 
Raw Materials Spectra and Loading Factor 
NIR and Raman Models 
Considering the Root Mean Squared Error of Calibration (RMSEC) and the Root Mean Squared Error of Prediction 
(RMSEP) of the NIR model, their values are 1.92 and 1.66 respectively, indicating the robustness and the global 
accuracy of the NIR model. For the Raman model, the RMSEC and the RMSEP are 1.96 and 2.64 respectively. 
Figures 7 and 8 show the agreement observed between the NIR and the Raman predictions and the reference 
method results for both calibration and validation sets (in green). 
NIR and Raman Predictions 
Reference Method      
Each implant was cut in 20 pieces and was put into a flask with 100 mL of methanol. The flask was heat  to reflux 
during 2 hours. Then, 1mL of the methanol solution was withdraw and put into a volumetric flask of 250 mL of 
phosphate buffer. The solution was analyzed with HPLC method which was validated using the accuracy profile 
approach (β-expectation  tolerance limits: 95% and α risk: 5%). 
NIR and Raman spectroscopy were found to be suitable techniques to determine the API content within implants 
during the process. Theses techniques are very fast (only 5 seconds) compared with the reference method (min. 4 
hours). In-line process measurement allows to adapt some critical parameters during the process in order to ensure 
the right amount of API in this specific pharmaceutical formulation. Theses two different techniques provide 
comparable results. In fact, the RMSEC and RMSECV are very close in each PAT techniques. Predictions seem to 
be better for the NIR that for the Raman but the validation set is only composed with 50% (w/w) of API samples. 
Figure 4: Raman spectra of API, EVA and Final Product. 
Figure 6: Loading factors of the NIR PLS model. 
Figure 7: NIR predictions versus reference method results for 
calibration and validation sets. 
